InsiderClue
← All stocks

Kura Oncology, Inc.

KURA Net buying
CIK 0001422143 #2514 in the set updated 17 Sep 2026
Bought (12 mo)
$2.35M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$3.28M
$1.75M on a plan · $341.70K straight out of an exercise
Sold at will
$1.19M
23 of 36 sales
Net
−$930.94K
+$1.17M against sales at will

By person

9 insiders · 40 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
WILSON TROY EDWARD
President and CEO
$2.35M (2)
$327.42K (1)
+$2.02M
914,650
1.03%
$11.33M
+226.5%
Leoni Mollie
Chief Medical Officer
—
$1.19M (7) scheduled
−$1.19M
182,345
0.2050%
$2.26M
+288.2%
Bair Teresa Brophy
Chief Legal Officer
—
$690.81K (7) scheduled
−$690.81K
195,444
0.2197%
$2.42M
+168.5%
Powl Brian T.
Chief Commercial Officer
—
$397.89K (7)
−$397.89K
169,269
0.1903%
$2.10M
+979.7%
Burrows Francis
Chief Scientific Officer
—
$243.02K (2) scheduled
−$243.02K
32,424
0.0364%
$401.73K
+31.7%
FORD KATHLEEN
Chief Operating Officer
—
$174.59K (4) scheduled
−$174.59K
153,560
0.1726%
$1.90M
+22.5%
DOYLE THOMAS JAMES
SVP, Finance & Accounting
—
$151.76K (7)
−$151.76K
145,167
0.1632%
$1.80M
+175.7%
Hasnain Faheem
Director
—
$109.76K (1) scheduled
−$109.76K
23,983
0.0270%
$297.15K
0.0%
Malley Thomas
Director
—
—
—
10,000
0.0112%
$123.90K
—

Individual transactions

2
Insider
Date
Role
Action
Shares
Price
Amount
WILSON TROY EDWARD
24 Aug 2026
President and CEO
Buy indirect
100,000
$12.39
$1.24M
WILSON TROY EDWARD
17 Aug 2026
President and CEO
Buy indirect
100,000
$11.12
$1.11M
Show all 40 transactions →

What was left out

Form 4 filings counted 46
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 11
Sales straight out of an exercise 2
Sales at will 23
Transactions with no price 0
Shares from compensation/vesting 1,155,686
History held since 3 Jan 2017